Literature DB >> 10698690

Evidence for regulation of NF-kappaB by poly(ADP-ribose) polymerase.

M Kameoka1, K Ota, T Tetsuka, Y Tanaka, A Itaya, T Okamoto, K Yoshihara.   

Abstract

The DNA-binding activity of NF-kappaB in nuclear extracts of poly(ADP-ribose) polymerase (PARP)-defective mutant L1210 cell clones was markedly increased and was inversely correlated with the PARP content in these cells. The DNA-binding activity of NF-kappaB in a clone with the lowest PARP content (Cl-3527, contained 6% of PARP of wild type cells) was about 35-fold of that of the wild-type cells, whereas the change in the DNA-binding activity of AP-1 and SP-1 in the mutant was relatively small or not so significant. Transfection of a PARP-expressing plasmid to the mutant cells decreased the abnormally high levels of NF-kappaB complexes, especially p50/p65(Rel A) complex, to near the normal level. Moreover, poly(ADP-ribosyl)ation of nuclear extracts in vitro suppressed the ability of NF-kappaB to form a complex with its specific DNA probe by approx. 80%. Further analysis with purified recombinant NF-kappaB proteins revealed that both rp50 and rMBP-p65 (Rel A) proteins, but not rGST-IkappaB, could be poly(ADP-ribosyl)ated in vitro and that the modification resulted in a marked decrease in the DNA-binding activity of rMBP-p65, whereas a slight activation was observed in rp50. Poly(ADP-ribosyl)ated p65/NF-kappaB was detected in the cytosol of wild type L1210 cells by immunoblotting with anti-poly(ADP-ribose) and anti-p65 antibodies. Taken together, these results strongly suggest that PARP is involved in the regulation of NF-kappaB through the protein modification.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10698690      PMCID: PMC1220896     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  52 in total

1.  Regulation by ADP-ribosylation.

Authors:  G de Murcia; M Jacobson; S Shall
Journal:  Trends Cell Biol       Date:  1995-02       Impact factor: 20.808

2.  Age-dependent increase of DNA topoisomerase II activity in quail oviduct; modulation of the nuclear matrix-associated enzyme activity by protein phosphorylation and poly(ADP-ribosyl)ation.

Authors:  H C Schröder; R Steffen; R Wenger; D Ugarković; W E Müller
Journal:  Mutat Res       Date:  1989 Sep-Nov       Impact factor: 2.433

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Inhibition of DNA polymerase alpha, DNA polymerase beta, terminal deoxynucleotidyl transferase, and DNA ligase II by poly(ADP-ribosyl)ation reaction in vitro.

Authors:  K Yoshihara; A Itaya; Y Tanaka; Y Ohashi; K Ito; H Teraoka; K Tsukada; A Matsukage; T Kamiya
Journal:  Biochem Biophys Res Commun       Date:  1985-04-16       Impact factor: 3.575

5.  Mechanism of the inhibition of Ca2+, Mg2+-dependent endonuclease of bull seminal plasma induced by ADP-ribosylation.

Authors:  Y Tanaka; K Yoshihara; A Itaya; T Kamiya; S S Koide
Journal:  J Biol Chem       Date:  1984-05-25       Impact factor: 5.157

6.  PARP-2, A novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase.

Authors:  J C Amé; V Rolli; V Schreiber; C Niedergang; F Apiou; P Decker; S Muller; T Höger; J Ménissier-de Murcia; G de Murcia
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

7.  Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice.

Authors:  F J Oliver; J Ménissier-de Murcia; C Nacci; P Decker; R Andriantsitohaina; S Muller; G de la Rubia; J C Stoclet; G de Murcia
Journal:  EMBO J       Date:  1999-08-16       Impact factor: 11.598

8.  TFIIF, a basal eukaryotic transcription factor, is a substrate for poly(ADP-ribosyl)ation.

Authors:  J M Rawling; R Alvarez-Gonzalez
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

9.  Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease.

Authors:  Z Q Wang; B Auer; L Stingl; H Berghammer; D Haidacher; M Schweiger; E F Wagner
Journal:  Genes Dev       Date:  1995-03-01       Impact factor: 11.361

10.  DNA strand breaks and poly(ADP-ribose) synthetase activation in pancreatic islets--a new aspect to development of insulin-dependent diabetes and pancreatic B-cell tumors.

Authors:  H Okamoto; H Yamamoto
Journal:  Princess Takamatsu Symp       Date:  1983
View more
  36 in total

Review 1.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

2.  Differential regulation of CXC ligand 1 transcription in melanoma cell lines by poly(ADP-ribose) polymerase-1.

Authors:  K I Amiri; H C Ha; M E Smulson; A Richmond
Journal:  Oncogene       Date:  2006-06-26       Impact factor: 9.867

Review 3.  Role of PARP-1 in prostate cancer.

Authors:  Dhanraj Deshmukh; Yun Qiu
Journal:  Am J Clin Exp Urol       Date:  2015-04-25

4.  Poly(ADP-ribose) polymerase-1 is required for efficient HIV-1 integration.

Authors:  H C Ha; K Juluri; Y Zhou; S Leung; M Hermankova; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

5.  Noncleavable poly(ADP-ribose) polymerase-1 regulates the inflammation response in mice.

Authors:  Virginie Pétrilli; Zdenko Herceg; Paul O Hassa; Nimesh S A Patel; Rosanna Di Paola; Ulrich Cortes; Laura Dugo; Helder-Mota Filipe; Christoph Thiemermann; Michael O Hottiger; Salvatore Cuzzocrea; Zhao-Qi Wang
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

6.  Poly(ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency.

Authors:  Eriko Ohsaki; Keiji Ueda; Shuhei Sakakibara; Eunju Do; Kaori Yada; Koichi Yamanishi
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

7.  Poly(ADP-ribose) polymerase-1 enhances transcription of the profibrotic CCN2 gene.

Authors:  Hirokazu Okada; Tsutomu Inoue; Tomohiro Kikuta; Nobutaka Kato; Yoshihiko Kanno; Narumi Hirosawa; Yasushi Sakamoto; Takeshi Sugaya; Hiromichi Suzuki
Journal:  J Am Soc Nephrol       Date:  2008-02-20       Impact factor: 10.121

8.  Upregulation of Salmonella-induced IL-6 production in Caco-2 cells by PJ-34, PARP-1 inhibitor: involvement of PI3K, p38 MAPK, ERK, JNK, and NF-kappaB.

Authors:  Fu-Chen Huang
Journal:  Mediators Inflamm       Date:  2010-02-24       Impact factor: 4.711

9.  PARP-1 deficiency increases the severity of disease in a mouse model of multiple sclerosis.

Authors:  Vimal Selvaraj; Mangala M Soundarapandian; Olga Chechneva; Ambrose J Williams; Maxim K Sidorov; Athena M Soulika; David E Pleasure; Wenbin Deng
Journal:  J Biol Chem       Date:  2009-07-23       Impact factor: 5.157

Review 10.  Potential biological role of poly (ADP-ribose) polymerase (PARP) in male gametes.

Authors:  Ashok Agarwal; Reda Z Mahfouz; Rakesh K Sharma; Oli Sarkar; Devna Mangrola; Premendu P Mathur
Journal:  Reprod Biol Endocrinol       Date:  2009-12-05       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.